Enfusion, Inc.

NYSE ENFN

Enfusion, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 3.58%

Enfusion, Inc. EBIT Margin is 3.58% for the Trailing 12 Months (TTM) ending September 30, 2024, a 3,242.29% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Enfusion, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was -0.11%, a 99.95% change year over year.
  • Enfusion, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -216.71%, a -5,962.88% change year over year.
  • Enfusion, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 3.70%.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Loading...
NYSE: ENFN

Enfusion, Inc.

CEO Mr. Oleg Movchan
IPO Date Oct. 21, 2021
Location United States
Headquarters 125 South Clark Street
Employees 1,102
Sector Finance
Industries
Description

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.

Similar companies

CWAN

Clearwater Analytics Holdings, Inc.

USD 26.45

2.12%

PYCR

Paycor HCM, Inc.

USD 22.09

-0.09%

BRZE

Braze, Inc.

USD 41.86

0.62%

ONTF

ON24, Inc.

USD 6.32

2.10%

PRO

PROS Holdings, Inc.

USD 21.95

1.67%

FRSH

Freshworks Inc.

USD 16.13

3.40%

ETWO

E2open Parent Holdings, Inc.

USD 2.59

1.57%

LAW

CS Disco, Inc.

USD 4.96

1.02%

MLNK

MeridianLink, Inc.

USD 18.95

-0.32%

BLKB

Blackbaud, Inc.

USD 75.10

0.31%

StockViz Staff

January 15, 2025

Any question? Send us an email